Patents by Inventor Yin-Peng Chen

Yin-Peng Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11851720
    Abstract: Provided herein are methods for identifying the presence or absence of a target nucleic acid from a microorganism using direct amplification without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods assaying extracted nucleic acids.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: December 26, 2023
    Assignee: Quest Diagnostics Investments LLC
    Inventors: Maurice Exner, Luca Jacky, Yin-Peng Chen, Huong Mai, Michelle M. Tabb, Michael Aye
  • Publication number: 20200340068
    Abstract: Provided herein are methods for identifying the presence or absence of a target nucleic acid from a microorganism using direct amplification without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods assaying extracted nucleic acids.
    Type: Application
    Filed: April 10, 2020
    Publication date: October 29, 2020
    Applicant: Quest Diagnostics Investments LLC
    Inventors: Maurice Exner, Luca Jacky, Yin-Peng Chen, Huong Mai, Michelle M. Tabb, Michael Aye
  • Patent number: 10619220
    Abstract: Provided herein are methods for identifying the presence or absence of a target nucleic acid from a microorganism using direct amplification without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods assaying extracted nucleic acids.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: April 14, 2020
    Assignee: Quest Diagnostics Investments Incorporated
    Inventors: Maurice Exner, Luca Jacky, Yin-Peng Chen, Huong Mai, Michelle M. Tabb, Michael Aye
  • Publication number: 20170081735
    Abstract: Provided herein are methods for identifying the presence or absence of a target nucleic acid from a microorganism using direct amplification without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods as-saying saying extracted nucleic acids.
    Type: Application
    Filed: October 7, 2016
    Publication date: March 23, 2017
    Applicant: Quest Diagnostics Investments Incorporated
    Inventors: Maurice Exner, Luca Jacky, Yin-Peng Chen, Huong Mai, Michelle M. Tabb, Michael Aye
  • Patent number: 9464331
    Abstract: Provided are methods for identifying the presence or absence of a target nucleic acid from a microorganism using direct amplification without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods assaying extracted nucleic acids. Further provided are reagent mixtures that allow for direct amplification of a sample, without the step of nucleic acid extraction.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: October 11, 2016
    Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATED
    Inventors: Maurice Exner, Luca Jacky, Yin-Peng Chen, Huong Mai, Michelle M. Tabb, Michael Aye
  • Patent number: 9194006
    Abstract: Provided herein are methods for identifying the presence or absence of a target nucleic acid from a microorganism using direct amplification without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods assaying extracted nucleic acids.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: November 24, 2015
    Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATED
    Inventors: Maurice Exner, Luca Jacky, Yin-Peng Chen, Huong Mai, Jules Chen, Michelle M. Tabb, Michael Aye, Emberlee Eleazar
  • Publication number: 20140234830
    Abstract: Provided are methods for identifying the presence or absence of a target nucleic acid from a microorganism using direct amplification without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods assaying extracted nucleic acids. Further provided are reagent mixtures that allow for direct amplification of a sample, without the step of nucleic acid extraction.
    Type: Application
    Filed: July 6, 2012
    Publication date: August 21, 2014
    Applicant: QUEST DIAGNOSTICS INVESTMENTS INCORPORATED
    Inventors: Maurice Exner, Luca Jacky, Yin-Peng Chen, Huong Mai, Michelle M. Tabb, Michael Aye
  • Publication number: 20130022963
    Abstract: Provided herein are methods for identifying the presence or absence of a target nucleic acid from a microorganism using direct amplification without a step of extraction of the nucleic acids, but retaining substantially the same specificity and sensitivity of methods assaying extracted nucleic acids.
    Type: Application
    Filed: July 6, 2012
    Publication date: January 24, 2013
    Inventors: MAURICE EXNER, LUCA JACKY, YIN-PENG CHEN, HUONG MAI, JULES CHEN, MICHELLE M. TABB, MICHAEL AYE, EMBERLEE ELEAZAR
  • Publication number: 20060148103
    Abstract: Biological assay systems with enhanced sensitivity may employ waveguides. Quantum dots, which are inorganic fluorescent markers, may be used as markers that will indicate a presence of amount of one or more target molecules (e.g., analytes) in a sample. Multiple markers may be bound to each target molecule or a corresponding competitive molecule to provide a more intense signal from each such molecule and, thus, increased sensitivity. Such multiple binding may be effected by cascading techniques, by binding markers to multiple sites on a target molecule or corresponding competitive molecule, or otherwise.
    Type: Application
    Filed: December 30, 2004
    Publication date: July 6, 2006
    Inventors: Yin-Peng Chen, Stephan Thompson, Thomas Grove